Advertisement

Supportive Care in Cancer

, Volume 23, Issue 9, pp 2843–2851 | Cite as

A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients

  • Trina ThorneEmail author
  • Karin Olson
  • Wendy Wismer
Review Article

Abstract

Purpose

The purpose of this review was to examine studies of interventions for the prevention and management of taste and smell alterations (TSA) experienced by adult oncology patients.

Methods

Articles published between 1993 and 2013 were identified by searching CINAHL, MEDLINE and Food Science & Technology Abstracts (FSTA) and were included if they were in English and focused on adult oncology patients. Only interventions within the scope of nursing practice were reviewed.

Results

Twelve articles were identified for inclusion. Four research groups examined zinc supplementation, with two claiming that zinc supplementation was an effective intervention and two claiming it had no effect on TSA. The remaining research groups examined eight other interventions, with varying results. Marinol, megestrol acetate and Synsepalum dulcificum interventions appear promising.

Conclusion

Based on this review, there does not yet appear to be an effective approach for preventing or managing TSA in adult oncology patients. Although some interventions show promise, further research is necessary to determine their efficacy.

Keywords

Taste Smell Dysgeusia Chemosensory Neoplasm Cancer 

Notes

Conflict of interest

The authors declare that they have no competing interests. The authors have full control of all primary data and permit the journal to review the data if requested.

References

  1. 1.
    McLaughlin L, Mahon SM (2012) Understanding taste dysfunction in patients with cancer. Clin J Oncol Nurs 16(2):171–178PubMedCrossRefGoogle Scholar
  2. 2.
    Ravasco P (2005) Aspects of taste and compliance in patients with cancer. Eur J Oncol Nurs 9:S84–S91PubMedCrossRefGoogle Scholar
  3. 3.
    Hovan AJ, Williams MP, Stevenson-Moore P, et al (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18:1081–1087PubMedCrossRefGoogle Scholar
  4. 4.
    Hutton JL, Baracos VE, Wismer WV (2007) Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manag 33(2):156–165CrossRefGoogle Scholar
  5. 5.
    Yakirevitch A, Bercovici M, Migirov L, et al (2006) Olfactory function in oncologic hospice patients. J Palliat Med 9(1):57–60PubMedCrossRefGoogle Scholar
  6. 6.
    Mahmoud FA, Aktas A, Walsh D, et al (2011) A pilot study of taste changes among hospice inpatients with advanced cancer. Am J Hosp Palliat Med 28(7):487–492CrossRefGoogle Scholar
  7. 7.
    Zabernigg A, Gamper E, Giesinger JM, et al (2010) Taste alterations in cancer patients receiving chemotherapy: a neglected side effect? Oncologist 15(8):913–920PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Grant MJ, Booth A (2009) A typology of reviews: an analysis of 14 review types and associated methodologies. Health Inf Libr J 26:91–108CrossRefGoogle Scholar
  9. 9.
    Brisbois TD, de Kock IH, Watanabe SM, et al (2011) Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double blind, placebo-controlled pilot trial. Ann Oncol 22:2086–2093PubMedCrossRefGoogle Scholar
  10. 10.
    Lyckholm L, Heddinger SP, Parker G, et al (2012) A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders. J Pain Palliat Care Pharmacother 26(2):111–114PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Rehwaldt M, Wickham R, Purl S, et al (2009) Self-care strategies to cope with taste changes after chemotherapy. Oncol Nurs Forum 36(2):E47–E56PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Ripamonti C, Zecca E, Brunelli C, et al (1998) A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer 82(10):1938–1945PubMedCrossRefGoogle Scholar
  13. 13.
    Schiffman SS, Sattely-Miller EA, Taylor EL, et al (2007) Combination of flavor enhancement and chemosensory education improves nutritional status in older cancer patients. J Nutr Health Aging 11(5):439–454PubMedGoogle Scholar
  14. 14.
    Wilken MK, Satiroff BA (2012) Pilot study of “miracle fruit” to improve food palatability for patients receiving chemotherapy. Clin J Oncol Nurs 16(5):E173–E177PubMedCrossRefGoogle Scholar
  15. 15.
    Buntzel J, Glatzel M, Mucke R, et al (2007) Influence of amifostine on late radiation-toxicity in head and neck cancer: a follow up study. Anticancer Res 27:1953–1956PubMedGoogle Scholar
  16. 16.
    Jham BC, Chen H, Carvalho AL, et al (2009) A randomized phase III prospective trial of bethanechol to prevent mucositis, candidiasis, and taste loss in patients with head and neck cancer undergoing radiotherapy: a secondary analysis. J Oral Sci 51(4):565–572PubMedCrossRefGoogle Scholar
  17. 17.
    Strasser F, Demmer R, Böhme C, et al (2008) Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double blind study. Oncologist 13(3):337–346PubMedCrossRefGoogle Scholar
  18. 18.
    Yamagata T, Nakamura Y, Yamagata Y, et al (2003) The pilot trial of the prevention of the increase in electrical taste thresholds by zinc containing fluid infusion during chemotherapy to treat primary lung cancer. J Exp Clin Cancer Res 22(4):557–563PubMedGoogle Scholar
  19. 19.
    Erkurt E, Erkisi M, Tunali C (2000) Supportive treatment in weight-losing cancer patients due to the additive adverse effects of radiation treatment and/or chemotherapy. J Exp Clin Cancer Res 19(4):431–439PubMedGoogle Scholar
  20. 20.
    Halyard MY et al (2007) Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys 67(5):1318–1322PubMedCrossRefGoogle Scholar
  21. 21.
    Teulings FA, van Gilse HA, Henkelman MS, et al (1980) Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer. Cancer Res 40(7):2557–2561PubMedGoogle Scholar
  22. 22.
    Kouvaris JR, Kouloulias VE, Vlahos LJ (2007) Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist 12(6):738–747PubMedCrossRefGoogle Scholar
  23. 23.
    Hong JH, Omur-Ozbek P, Stanek BT, et al (2009) Taste and odor abnormalities in cancer patients. J Support Oncol 7(2):58–65PubMedGoogle Scholar
  24. 24.
    Epstein JB, Thariat J, Bensadoun RJ, et al (2012) Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 62(6):400–422PubMedCrossRefGoogle Scholar
  25. 25.
    Lawless HT, Heymann H (2010) Sensory evaluation of food: principles and practices, 2nd edn. Chapman & Hall, New York, p. 596CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.University of AlbertaEdmontonCanada
  2. 2.Faculty of NursingUniversity of AlbertaEdmontonCanada
  3. 3.Department of Agriculture, Food and Nutritional ScienceUniversity of AlbertaEdmontonCanada
  4. 4.St. AlbertCanada

Personalised recommendations